BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAH4. A total of 41 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $405,000 | -5.6% | 400,000 | 0.0% | 0.00% | – |
Q4 2020 | $429,000 | +2.1% | 400,000 | 0.0% | 0.00% | – |
Q3 2020 | $420,000 | -14.1% | 400,000 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $489,000 | +16.7% | 400,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $419,000 | -0.9% | 400,000 | 0.0% | 0.00% | – |
Q4 2019 | $423,000 | +7.6% | 400,000 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $393,000 | -5.3% | 400,000 | 0.0% | 0.00% | – |
Q2 2019 | $415,000 | -88.4% | 400,000 | -88.5% | 0.00% | -100.0% |
Q1 2019 | $3,567,000 | +6.4% | 3,487,000 | +3.5% | 0.01% | +66.7% |
Q4 2018 | $3,351,000 | -15.1% | 3,370,000 | -9.1% | 0.00% | -40.0% |
Q3 2018 | $3,949,000 | -2.6% | 3,706,000 | -7.7% | 0.01% | -16.7% |
Q2 2018 | $4,056,000 | -65.4% | 4,015,000 | -67.9% | 0.01% | -68.4% |
Q1 2018 | $11,736,000 | -2.0% | 12,501,000 | +4.0% | 0.02% | +5.6% |
Q4 2017 | $11,975,000 | +47.7% | 12,020,000 | +50.2% | 0.02% | -30.8% |
Q3 2017 | $8,105,000 | – | 8,000,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERBACK ASSET MANAGEMENT LLC | 36,000,000 | $36,583,000 | 5.85% |
Man Investments (CH) AG | 3,200,000 | $3,250,000 | 2.78% |
Verde Servicos Internacionais S.A. | 11,000,000 | $11,165,000 | 2.06% |
Jabre Capital Partners S.A. | 10,000,000 | $10,156,000 | 1.97% |
LINDEN ADVISORS LP | 38,500,000 | $39,095,000 | 1.39% |
Opera Trading Capital | 9,900,000 | $9,925,000 | 1.35% |
Sonora Investment Management, LLC | 4,950,000 | $5,029,596,000 | 0.87% |
CQS Cayman LP | 10,000,000 | $10,165,000 | 0.68% |
Polar Asset Management Partners Inc. | 25,000,000 | $25,384,000 | 0.51% |
ADVENT CAPITAL MANAGEMENT /DE/ | 26,000,000 | $26,383,000 | 0.50% |